Uncategorised - European Medical Journal

Breakthrough in Relapsed DLBCL Treatment

A Phase III clinical trial, ECHELON-3, has demonstrated survival benefits for patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) using a combination therapy of brentuximab vedotin (BV), lenalidomide (Len), and rituximab (R).

Pulse Points: Advancing Cardiovascular Medicine

In this episode, Jonathan Sackier is joined by Eric Secemsky, a world-renowned interventional cardiologist whose innovative research and clinical expertise are redefining cardiovascular care.

Canadian Wildfires Increase Lung Risks in Eastern US

The growing health crisis posed by wildfire smoke, even from thousands of miles away, was made clear in a recently published study.

Limited Value of Routine Follow-Up in Lymphoma Remission

Study reveals limited effectiveness of routine follow-up in detecting relapses in diffuse large B-cell lymphoma patients in remission.

Needle-free vaccine technology wins $3.7m in funding from CEPI

Micron Biomedical, an Atlanta-based life sciences company, has received funding for its technology that could improve vaccine access.

Exploring Stress Response Pathways in Prostate Cancer

Recent research sheds light on a promising therapeutic strategy for tackling prostate cancer by targeting the integrated stress response kinase GCN2.

Global Lung Cancer Risk: Men and Wealthy Nations Hit Hardest

1 in 28 people globally will develop lung cancer, with men and wealthy nations at greatest risk, highlighting urgent healthcare disparities.

New MRI Lung Scan Technique Offers Hope for Patients Receiving Lung Transplant

New MRI lung scanning method could change treatment for compromised lung function in transplant patients.

AI Detects Parkinson’s with Near-Perfect Accuracy by Analysing Emotions

Groundbreaking study uses EEG and AI to diagnose Parkinson’s disease with near-perfect accuracy through emotional response analysis.

AI-Powered ECG Tool Predicts Hypertension and Adverse Events

AI-enhanced ECG predicts hypertension and identifies patients at risk for adverse events, transforming preventive care approaches.